Sixteen Weeks of Resistance Training in Hypertensive Elderly, Effects on Heart Rate Variability

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT03254225
Collaborator
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. (Other)
40
1
2
36.9
1.1

Study Details

Study Description

Brief Summary

This study evaluates the inffluence of 16 weeks of resistance training on heart rate variability of hypertensive elderlies patients. All volunteers will be divided in two groups, one will participate in a protocol of sixteen weeks of resistance training, an the other will remain sedentary.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Resistance training
N/A

Detailed Description

This study evaluates the inffluence of 16 weeks of resistance training on heart rate variability using time and frequency-domains by ECG tracks. Will be assessed the blood pressure using the ambulatory blood pressure monitoring method of hypertensive elderly patients. All volunteers will be divided in two groups, one will participate in a protocol of sixteen weeks of resistance training prescribed with a relative workload of 50% of 1 maximal repetition, an the ontrol group will remain sedentary.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Sixteen Weeks of Resistance Training in Hypertensive Elderly, Effects on Heart Rate Variability
Actual Study Start Date :
Apr 4, 2018
Actual Primary Completion Date :
Jan 30, 2020
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Resistance training

Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).

Behavioral: Resistance training
Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).

No Intervention: Control

in this arm, the group will remain sedentary for the same period of the experimental group, and they will be invited to engage on the raining program after the sedentary period

Outcome Measures

Primary Outcome Measures

  1. Blood pressure change due to resistance training [16 weeks]

    Blood pressure will be measured by Ambulatorial Monitoring Blood Pressure before and after 16 weeks of intervention.

Secondary Outcome Measures

  1. Heart rate variability - Time domain - change due to resistance training [16 weeks]

    Heart rate variability will be collected by electrocardiogram before and after 16 weeks of intervention

  2. Heart rate variability - Frequency domain - change due to resistance training [16 weeks]

    Heart rate variability will be collected by electrocardiogram before and after 16 weeks of intervention

  3. Heart rate variability - Non-linear methods - change due to resistance training [16 weeks]

    Heart rate variability will be collected by electrocardiogram before and after 16 weeks of intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hypertensives

  • Age 60 to 80 years

  • Nonactive

Exclusion Criteria:
  • Orthopedic problems or other problem that prevented the exercises

  • Change in drug treatment during protocol

  • Absence in more than 25% of the exercise sessions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fabio Tanil Montrezol Santos Sao Paulo Brazil 11070061

Sponsors and Collaborators

  • Federal University of São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Investigators

  • Principal Investigator: Fabio T Montrezol, Federal University of São Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alessandra Medeiros, Principal Investigator, Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT03254225
Other Study ID Numbers:
  • CEP1844640
First Posted:
Aug 18, 2017
Last Update Posted:
Mar 17, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alessandra Medeiros, Principal Investigator, Federal University of São Paulo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2022